|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 107.94 CHF | +0.43% |
|
+2.18% | +21.44% |
| 08:29pm | GSK wins US approval for twice-yearly asthma drug | RE |
| 12-16 | NOVARTIS AG : Gets a Buy rating from Deutsche Bank | ZD |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 110.33 | 114.48 | 116.84 |
| Spread/Res. | -2.36% | -5.91% | -7.81% |
| Spread/Supp. | +3.32% | +7.27% | +11.80% |
| Support | 104.26 | 100.42 | 96.35 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- NOVN Stock
- Charts Novartis AG
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition